Your browser doesn't support javascript.
loading
Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network.
Blanc-Durand, Paul; Jégou, Simon; Kanoun, Salim; Berriolo-Riedinger, Alina; Bodet-Milin, Caroline; Kraeber-Bodéré, Françoise; Carlier, Thomas; Le Gouill, Steven; Casasnovas, René-Olivier; Meignan, Michel; Itti, Emmanuel.
Afiliación
  • Blanc-Durand P; Department of Nuclear Medicine, CHU H. Mondor, AP-HP, F-94010, Créteil, France. paul.blancdurand@aphp.fr.
  • Jégou S; LYmphoma Study Association (LYSA), Pierre-Bénite, France. paul.blancdurand@aphp.fr.
  • Kanoun S; INSERM IMRB Team 8, U-PEC, F-94000, Créteil, France. paul.blancdurand@aphp.fr.
  • Berriolo-Riedinger A; INRIA Epione Team, Sophia Antipolis, France. paul.blancdurand@aphp.fr.
  • Bodet-Milin C; Service de Médecine Nucléaire, CHU Henri Mondor, 51 ave. Du Mal de Lattre de Tassigny, 94010, Créteil, France. paul.blancdurand@aphp.fr.
  • Kraeber-Bodéré F; Owkin, F-75010, Paris, France.
  • Carlier T; LYmphoma Study Association (LYSA), Pierre-Bénite, France.
  • Le Gouill S; Department of Nuclear Medicine, Institut C. Regaud, F-31000, Toulouse, France.
  • Casasnovas RO; LYmphoma Study Association (LYSA), Pierre-Bénite, France.
  • Meignan M; Department of Nuclear Medicine, Centre G.-F. Leclerc, F-21000, Dijon, France.
  • Itti E; LYmphoma Study Association (LYSA), Pierre-Bénite, France.
Eur J Nucl Med Mol Imaging ; 48(5): 1362-1370, 2021 05.
Article en En | MEDLINE | ID: mdl-33097974
ABSTRACT

PURPOSE:

Lymphoma lesion detection and segmentation on whole-body FDG-PET/CT are a challenging task because of the diversity of involved nodes, organs or physiological uptakes. We sought to investigate the performances of a three-dimensional (3D) convolutional neural network (CNN) to automatically segment total metabolic tumour volume (TMTV) in large datasets of patients with diffuse large B cell lymphoma (DLBCL).

METHODS:

The dataset contained pre-therapy FDG-PET/CT from 733 DLBCL patients of 2 prospective LYmphoma Study Association (LYSA) trials. The first cohort (n = 639) was used for training using a 5-fold cross validation scheme. The second cohort (n = 94) was used for external validation of TMTV predictions. Ground truth masks were manually obtained after a 41% SUVmax adaptive thresholding of lymphoma lesions. A 3D U-net architecture with 2 input channels for PET and CT was trained on patches randomly sampled within PET/CTs with a summed cross entropy and Dice similarity coefficient (DSC) loss. Segmentation performance was assessed by the DSC and Jaccard coefficients. Finally, TMTV predictions were validated on the second independent cohort.

RESULTS:

Mean DSC and Jaccard coefficients (± standard deviation) in the validations set were 0.73 ± 0.20 and 0.68 ± 0.21, respectively. An underestimation of mean TMTV by - 12 mL (2.8%) ± 263 was found in the validation sets of the first cohort (P = 0.27). In the second cohort, an underestimation of mean TMTV by - 116 mL (20.8%) ± 425 was statistically significant (P = 0.01).

CONCLUSION:

Our CNN is a promising tool for automatic detection and segmentation of lymphoma lesions, despite slight underestimation of TMTV. The fully automatic and open-source features of this CNN will allow to increase both dissemination in routine practice and reproducibility of TMTV assessment in lymphoma patients.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Fluorodesoxiglucosa F18 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Fluorodesoxiglucosa F18 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Francia